共有 50 筆近期內部人交易記錄紀錄，涉及 Aptose Biosciences Inc. (APTO), 包括 41 筆買入 和 2 筆賣出. 內部人買入總額為 $4.06M 內部人賣出總額為 $51.5K.
近期活躍的重要內部人包括 Rice William G., Hanmi Pharmaceutical Co., Ltd., Ledru Philippe. 內部人交易記錄可以揭示公司管理層對股票估值和未來前景的看法.
內部人交易記錄 — APTO
| 日期 |
姓名 |
職位 |
交易類型 |
股數 |
平均價格 |
總價值 |
持股數量 |
| 2027-06-06 |
Rice William G. |
Chair, President & CEO |
處置 |
50,000 |
$1.03 |
$51.5K |
- |
| 2025-03-18 |
Hanmi Pharmaceutical Co., Ltd. |
10 Percent Owner |
未知 |
- |
- |
- |
508,710 |
| 2024-11-25 |
Rice William G. |
Chair, President & CEO |
知情買入 |
50,000 |
$0.25 |
$12.5K |
50,000 |
| 2024-02-23 |
Ledru Philippe |
Officer |
未知 |
- |
- |
- |
- |
| 2024-02-05 |
Burger Denis R |
Director |
限制性股票授予 (RSU) |
3,333 |
$2.00 |
$6.67K |
3,333 |
| 2024-02-05 |
Platzer Erich |
Director |
限制性股票授予 (RSU) |
3,333 |
$2.00 |
$6.67K |
3,333 |
| 2024-02-05 |
Payne Fletcher |
Sr VP and CFO |
限制性股票授予 (RSU) |
55,000 |
$2.00 |
$110K |
55,000 |
| 2024-02-05 |
Vincent Mark D. |
Director |
限制性股票授予 (RSU) |
3,333 |
$1.97 |
$6.57K |
3,333 |
| 2024-02-05 |
Whitehead Warren |
Director |
限制性股票授予 (RSU) |
3,333 |
$1.97 |
$6.57K |
3,333 |
| 2024-02-05 |
Rice William G. |
Chair, President & CEO |
限制性股票授予 (RSU) |
70,000 |
$2.00 |
$140K |
70,000 |
| 2024-02-05 |
Ashe Carol Gail |
Director |
限制性股票授予 (RSU) |
3,333 |
$2.00 |
$6.67K |
3,333 |
| 2024-02-05 |
Seizinger Bernd R. |
Director |
限制性股票授予 (RSU) |
3,333 |
$2.00 |
$6.67K |
3,333 |
| 2024-02-05 |
Bejar Rafael |
Sr VP & Chief Medical Officer |
限制性股票授予 (RSU) |
35,000 |
$2.00 |
$70K |
35,000 |
| 2024-02-05 |
Ledru Philippe |
Sr VP & Ch Commerical Officer |
限制性股票授予 (RSU) |
11,000 |
$2.00 |
$22K |
11,000 |
| 2024-01-31 |
Hanmi Pharmaceutical Co., Ltd. |
10 Percent Owner |
未知 |
77,972 |
$51.30 |
$4M |
- |
| 2023-09-22 |
Seizinger Bernd R. |
Director |
知情買入 |
17,000 |
$3.14 |
$53.38K |
17,000 |
| 2023-01-19 |
Burger Denis R |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Platzer Erich |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Payne Fletcher |
Sr VP & Chief Fin. Officer |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Vincent Mark D. |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Whitehead Warren |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Rice William G. |
Chair, President & CEO |
限制性股票授予 (RSU) |
400,000 |
- |
- |
400,000 |
| 2023-01-19 |
Ashe Carol Gail |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Seizinger Bernd R. |
Director |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2023-01-19 |
Bejar Rafael |
Sr. VP, Chief Medical Officer |
限制性股票授予 (RSU) |
100,000 |
- |
- |
110,000 |
| 2023-01-19 |
Ledru Philippe |
Chief Commercial Officer |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,500 |
| 2022-09-19 |
Rice William G. |
Chair, President & CEO |
知情買入 |
10,000 |
$0.68 |
$6.83K |
363,252 |
| 2022-09-14 |
Seizinger Bernd R. |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.74 |
$37K |
50,000 |
| 2022-09-13 |
Seizinger Bernd R. |
Director |
未知 |
- |
- |
- |
- |
| 2022-07-06 |
Rice William G. |
Chair, President & CEO |
限制性股票授予 (RSU) |
600,000 |
$0.81 |
$486K |
600,000 |
| 2022-06-27 |
Payne Fletcher |
Officer |
未知 |
- |
- |
- |
- |
| 2022-06-27 |
Payne Fletcher |
Sr VP & Chief Fin. Officer |
限制性股票授予 (RSU) |
1,000,000 |
- |
- |
1,000,000 |
| 2022-06-06 |
Rice William G. |
Chair, President & CEO |
知情買入 |
10,000 |
$0.97 |
$9.68K |
353,252 |
| 2022-05-31 |
Loewy Caroline M |
Officer |
未知 |
- |
- |
- |
- |
| 2022-04-13 |
Ledru Philippe |
Chief Commercial Officer |
限制性股票授予 (RSU) |
600,000 |
- |
- |
600,000 |
| 2022-04-07 |
Ledru Philippe |
Chief Commercial Officer |
處置 |
- |
- |
- |
500 |
| 2022-01-18 |
Burger Denis R |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.34 |
$67K |
50,000 |
| 2022-01-18 |
Platzer Erich |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.34 |
$67K |
50,000 |
| 2022-01-18 |
Loewy Caroline M |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.34 |
$67K |
50,000 |
| 2022-01-18 |
Vincent Mark D. |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.39 |
$69.5K |
50,000 |
| 2022-01-18 |
Whitehead Warren |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.39 |
$69.5K |
50,000 |
| 2022-01-18 |
Rice William G. |
Chair, President & CEO |
限制性股票授予 (RSU) |
700,000 |
$1.34 |
$938K |
700,000 |
| 2022-01-18 |
Ashe Carol Gail |
Director |
限制性股票授予 (RSU) |
50,000 |
$1.34 |
$67K |
50,000 |
| 2022-01-18 |
Marango Jotin |
Senior VP, CFO, and Cbo |
限制性股票授予 (RSU) |
600,000 |
$1.34 |
$804K |
600,000 |
| 2022-01-18 |
Bejar Rafael |
Sr. VP, Chief Medical Officer |
限制性股票授予 (RSU) |
600,000 |
$1.34 |
$804K |
600,000 |
| 2021-12-20 |
Burger Denis R |
Director |
知情買入 |
10,000 |
$1.45 |
$14.49K |
31,671 |
| 2021-12-20 |
Burger Denis R |
Director |
未知 |
- |
- |
- |
- |
| 2021-12-16 |
Rice William G. |
Chair, President & CEO |
知情買入 |
13,183 |
$1.52 |
$20.04K |
343,252 |
| 2021-12-16 |
Platzer Erich |
Director |
知情買入 |
50,000 |
$1.37 |
$68.5K |
455,000 |
| 2021-12-15 |
Rice William G. |
Chair, President & CEO |
知情買入 |
17,822 |
$1.12 |
$19.96K |
330,069 |
■ 知情交易 — 公開市場買賣（最具參考價值）
■ 非知情買入 — 獎勵、期權行權、轉換
■ 非知情賣出 — 稅務代扣、歸屬出售
■ 中性 — 禮贈、信託、到期
